NutriBand (NTRB) Other Non-Current Liabilities (2019 - 2024)
NutriBand's (NTRB) quarterly Other Non-Current Liabilities came in at $300000.0 in Q2 2024, down 85.0% quarter-over-quarter from $2.0 million in Q4 2023.
NutriBand (NTRB) Other Non-Current Liabilities (2019 - 2024) Analysis & Trends
NutriBand has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $300000.0 for Q2 2024.
- Other Non-Current Liabilities for Q2 2024 came in at $300000.0, changed N/A year-over-year; the trailing twelve-month figure through Apr 2024 was $300000.0 (changed N/A YoY), and the FY2020 annual result was $928774.0, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $300000.0 for Q2 2024 at NutriBand, down from $2.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q4 2023 to a low of $300000.0 in Q2 2024.
- The 3-year median for Other Non-Current Liabilities is $928774.0 (2020), against an average of $1.1 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | NutriBand | 41.21 Mn | 36.63 Mn | 88,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 300,000.00 |
| Oct 31, 2023 | 2.00 Mn |
| Jan 31, 2020 | 928,774.00 |
| Oct 31, 2019 | 478,852.00 |
| Apr 30, 2019 | 928,774.00 |